跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
COR-2
首页
药物
COR-2
COR-2
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Therapeutic methods and compositions involving isoflavones
US 7202273 B2
申请人: NOVOGEN RES PTY LTD
优先权: 2002
US
5 件公开
Arene ruthenium complex, preparation method and utilization thereof
US 10358455 B2
申请人: UNIV GUANGDONG PHARM
优先权: 2017
CN
EP
US
3 件公开
Polyhydroxypyrazine derivatives, their preparation and the pharmaceutical compositions which comprise them
US 6818637 B2
申请人: AVENTIS PHARMA SA
优先权: 1999
CN
US
3 件公开
Cyanopyrroles
US 6982261 B2
申请人: LIGAND PHARM INC
优先权: 1999
CN
US
3 件公开
N-[(piperazinyl)hetary]arylsulfonamide compounds with affinity for the dopamine d3 receptor
US 2007054918 A1
申请人: BRAJE WILFRIED
优先权: 2003
CN
US
3 件公开
Novel piperidin-4-yl-thiazole-carboxamide analogues as inhibitors of T-cell proliferation and uses thereof
EP 1637529 A1
申请人: 4SC AG
优先权: 2004
CN
EP
3 件公开
Methods
US 7947468 B2
申请人: MEDICAL RES COUNCIL
优先权: 2008
CN
US
3 件公开
6-methoxy-2-naphthylacetic acid prodrugs
US 6525098 B1
申请人: NOBEX CORP
优先权: 2000
US
3 件公开
Hydroxamic and carboxylic acid derivatives
US 6680338 B2
申请人: DARWIN DISCOVERY LTD
优先权: 2001
US
3 件公开
Antibacterial compounds
US 6964970 B2
申请人: AFFINIUM PHARM INC
优先权: 2001
US
3 件公开
US 6987115 B2
申请人: SMITHKLINE BEECHAM CORP
优先权: 2003
US
2 件公开
第 1 / 10 页
上一页
下一页
药物
反馈